SCHEMBL1490874

SCHEMBL1490874

CC[C](NS(C)(=O)=O)c1cccc(NS(C)(=O)=O)c1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
POLB P06746 2/20 0.57
NR3C1 P04150 4/20 0.49
PGR P06401 3/20 0.49
NR3C2 P08235 3/20 0.49
AR P10275 3/20 0.49
HPGD P15428 1/20 0.48
PTGS2 P35354 2/20 0.47
HSD17B1 P14061 1/20 0.45
HSD17B2 P37059 1/20 0.45
KEAP1 Q14145 1/20 0.44
HTT P42858 1/20 0.42
F2 P00734 1/20 0.42
TP53 P04637 1/20 0.42
PRMT5 O14744 1/20 0.41
KIF11 P52732 1/20 0.40
DHX9 Q08211 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754989 0.81 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2POLBNR3C1PGR
SCHEMBL29398556 0.78 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2POLBNR3C1PGR
SCHEMBL6840090 0.77 ALDH1A1 (0.77) ALDH1A1SMN1; SMN2POLBNR3C1PGR
SCHEMBL11949257 0.76 SMN1; SMN2 (0.65) ALDH1A1SMN1; SMN2POLBNR3C1PGR
SCHEMBL29522198 0.76 ALDH1A1 (0.75) ALDH1A1SMN1; SMN2POLBHPGDKEAP1
SCHEMBL1677059 0.76 ALDH1A1 (0.75) ALDH1A1SMN1; SMN2POLBHPGDKEAP1
SCHEMBL334530 0.76 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2POLBHPGDKEAP1
SCHEMBL8563551 0.75 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2POLBNR3C1PGR
SCHEMBL3560486 0.75 POLB (0.73) ALDH1A1SMN1; SMN2POLBHPGD
SCHEMBL1490804 0.74 NPSR1 (0.48) ALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897609-B2 Aryl substituted imidazonaphthyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-01 US disclosed